Clinical Trials Directory

Trials / Unknown

UnknownNCT02471625

Traumatic Brain Injury Feasibility Study (EPIC-011)

Traumatic Brain Injury (TBI) Feasibility Study to Determine Possible Prognostic Indicators as Provided by the EPIC ClearView™

Status
Unknown
Phase
Study type
Observational
Enrollment
200 (estimated)
Sponsor
Epic Research & Diagnostics, Inc. · Industry
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

The purpose of this research study is to evaluate whether data made by the ClearView System can be used to detect whether someone has a traumatic brain injury and how severe the injury is.

Detailed description

Traumatic brain injury (TBI) is a significant cause of death and disability in the U.S. The severity of a TBI may range from "mild" (i.e. a brief change in mental status or consciousness) to "severe" (i.e. an extended period of unconsciousness or memory loss after the injury). However, most TBI's that occur each year are mild and are commonly called concussions. Unfortunately, TBI terminology does not adequately describe the injury or impairment, its treatment, or the resulting outcomes. Due to the complexity of the human brain, each person's physiology can result in different patterns of impairment and secondary conditions, requiring different treatment or rehabilitation. The intent of EPIC ClearView™ TBI Feasibility (EPIC-011) is to collect data to further develop the ClearView™ Response Scale to measure electrophysiology associated with TBI

Conditions

Interventions

TypeNameDescription
DEVICEClearView Scanning

Timeline

Start date
2015-04-01
Primary completion
2016-05-01
First posted
2015-06-15
Last updated
2015-11-20

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02471625. Inclusion in this directory is not an endorsement.